A team from chambers (James Mellor QC, Michael Tappin and Jessie Bowhill) recently represented Ranbaxy at the trial in the High Court of Ireland of its claim for a declaration of non-infringement of one of Warner-Lambert’s patents. The litigation concerns the cholesterol-lowering agent atorvastatin (sold by Warner-Lambert as Lipitor ®). Previously Michael Tappin had represented Ranbaxy in the UK litigation, with Richard Meade representing Warner-Lambert. The High Court in Dublin heard this case in January 2007 and gave judgment in July 2007.
+44(0)20 7405 4321
clerks@8newsquare.co.uk